U.S. flag

An official website of the United States government

NM_021830.5(TWNK):c.1853C>T (p.Pro618Leu) AND not provided

Germline classification:
Uncertain significance (3 submissions)
Last evaluated:
Aug 1, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000429667.8

Allele description [Variation Report for NM_021830.5(TWNK):c.1853C>T (p.Pro618Leu)]

NM_021830.5(TWNK):c.1853C>T (p.Pro618Leu)

Gene:
TWNK:twinkle mtDNA helicase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q24.31
Genomic location:
Preferred name:
NM_021830.5(TWNK):c.1853C>T (p.Pro618Leu)
Other names:
p.Pro618Leu
HGVS:
  • NC_000010.11:g.100993308C>T
  • NG_012624.1:g.10773C>T
  • NM_001163812.2:c.*148C>T
  • NM_001163813.2:c.491C>T
  • NM_001163814.2:c.*148C>T
  • NM_001368275.1:c.491C>T
  • NM_021830.3:c.1853C>T
  • NM_021830.5:c.1853C>TMANE SELECT
  • NP_001157285.1:p.Pro164Leu
  • NP_001355204.1:p.Pro164Leu
  • NP_068602.2:p.Pro618Leu
  • NC_000010.10:g.102753065C>T
  • NM_021830.4:c.1853C>T
  • NR_160738.1:n.2641C>T
  • NR_160739.1:n.845C>T
  • NR_160740.1:n.2503C>T
  • NR_160741.1:n.2459C>T
  • NR_160742.1:n.2623C>T
Protein change:
P164L
Links:
dbSNP: rs886046632
NCBI 1000 Genomes Browser:
rs886046632
Molecular consequence:
  • NM_001163812.2:c.*148C>T - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001163814.2:c.*148C>T - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001163813.2:c.491C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001368275.1:c.491C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_021830.5:c.1853C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_160738.1:n.2641C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_160739.1:n.845C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_160740.1:n.2503C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_160741.1:n.2459C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_160742.1:n.2623C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000526374GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Uncertain significance
(Mar 25, 2016)
germlineclinical testing

Citation Link,

SCV002541106Mayo Clinic Laboratories, Mayo Clinic
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Nov 12, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV003439635Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Aug 1, 2022)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

A multicenter clinical exome study in unselected cohorts from a consanguineous population of Saudi Arabia demonstrated a high diagnostic yield.

Alfares A, Alfadhel M, Wani T, Alsahli S, Alluhaydan I, Al Mutairi F, Alothaim A, Albalwi M, Al Subaie L, Alturki S, Al-Twaijri W, Alrifai M, Al-Rumayya A, Alameer S, Faqeeh E, Alasmari A, Alsamman A, Tashkandia S, Alghamdi A, Alhashem A, Tabarki B, AlShahwan S, et al.

Mol Genet Metab. 2017 Jun;121(2):91-95. doi: 10.1016/j.ymgme.2017.04.002. Epub 2017 Apr 7. No abstract available.

PubMed [citation]
PMID:
28454995
See all PubMed Citations (3)

Details of each submission

From GeneDx, SCV000526374.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The P618L variant in the C10orf2 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The P618L variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The P618L variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is not conserved. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret P618L as a variant of uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Mayo Clinic Laboratories, Mayo Clinic, SCV002541106.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003439635.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 298504). This variant is also known as C10orf2 c.1853C>T. This missense change has been observed in individual(s) with mitochondrial DNA depletion syndrome (PMID: 28454995). This variant is present in population databases (no rsID available, gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 618 of the TWNK protein (p.Pro618Leu). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024